Many cell lines are sensitive to growth at low cell density and undergo apoptosis induced by oxidative stress if the cell density is decreased below a critical threshold. In stable transfection experiments this cell density-dependent growth may be the limiting factor, since during drug selection the cell density falls below the critical threshold, precluding outgrowth of transfected clones. We describe here a simple protocol for the establishment of stably transfected human B cell lines making use of the protective action of antioxidants. 
The efficiency of establishing stably transfected cell lines is dependent, on the one hand, on the efficiency of gene transfer into a given cell line and, on the other hand, on the survival of successfully transfected cells when a selective pressure is applied. Since the efficiency of gene transfer into a given cell line can be easily determined using reporter plasmids whose gene products can be quantified enzymatically or visualized at the single cell level, most transfection protocols have attempted to improve the efficiency of transfection (e.g. by electroporation; [1] [2] [3] [4] [5] . Relatively little attention has, however, been devoted to the problem of survival and outgrowth of successfully transfected cell clones under selective conditions, which is the main focus of this work.
Before a cell line can be used for stable transfection and selection with a dominant marker, gene cell density and concentration of the drug have to be titrated against each other to determine the window in which selection is feasible. The lower the cell density, the better the selection at a given drug concentration, and above a critical cell density selection may not work at all. For the Burkitt's lymphoma (BL) line BL2, a cell line particularly critical in this respect, such a standard titration is shown in Figure 1A . It shows that at a cell density of 1280 per well (i.e. 12 800 cells/ml) a hygromycin concentration of at least 200-250 µg/ml and at a cell density of 2560 per well a hygromycin concentration of at least 250-300 µg/ml is required.
For many cell lines cell survival and cell growth are critically dependent on the cell density in culture. In standard tissue culture media, like RPMI 1640 with 10-20% fetal calf serum (FCS), many cell lines do not grow at densities below 100-1000 cells/ml. Some cell lines, like human EBV-negative and EBV-positive (so called group I) BL cell lines are exquisitely sensitive to seeding at low density and undergo apoptosis below a critical cell density of 10 000-50 000 cells/ml (6) . For BL2 cells the critical threshold in the experiment shown in Figure 1A is 1280 per well (i.e. 12 800 per ml). Drug selection with a dominant selectable marker kills the non-transfected cells, decreases the cell density below the critical threshold and thus drives the cells into apoptosis irrespective of whether the cells have taken up the dominant selectable marker gene or not. As a consequence, only cell lines that can be easily cloned and resist the selection conditions have been used for stable transfection experiments. In the case of BL cell lines, the feasibility versus non-feasibility of stable transfection experiments has dictated the use of cell lines such as DG75 and BJAB that deviate dramatically in their susceptibility to apoptosis from bona fide BL cells (6) (7) (8) . It has thus been impossible for technical reasons to stably transfect genes involved in the regulation of apoptosis into appropriate target cells more suitable for the study of gene effects.
We have studied the growth properties of BL cell lines in detail and have found that the sensitivity of BL cells to apoptosis is due to their limited ability to take up cystine from the medium (6, 8) . Since cystine uptake is the rate limiting step for synthesis of glutathione, the cells are unable to cope with increased oxidative *To whom correspondence should be addressed. Tel: +49 89 7099510; Fax: +49 89 7099500; Email: brielmeier@gsf.de stress to which they are exposed at low cell density. The cells can, however, grow at low density if a mixture of protective antioxidants is added (8) . Taking advantage of this knowledge we reasoned that outgrowth of stably transfected cell clones should be possible if the cells are plated in selective medium under conditions that protect the cells from apoptosis. We used HH514, a subclone of the BL cell line P3HR1, and BL2 as model systems to work out appropriate selection conditions. As shown in Figure 1B , cells can still proliferate if plated at low cell density in the presence of 1 mM sodium pyruvate (9,10), 50 µM α-thioglycerol (α-TG) and 20 nM bathocuproine disulfonate (BCS) (abbreviated to PTB) (8) . Figure 1B also shows that lower hygromycin concentrations can be applied if the cells are plated at lower density in the presence of PTB.
HH514 cells have been used successfully in our laboratory in transient transfection assays, but stable transfectants have been difficult to obtain (11, 12) . Transient transfections using an expression plasmid for green fluorescent protein (GFP) as a reporter gene revealed high transfection efficiencies, exceeding 50% in some experiments. Representative experiments are given in Table 1 . The transfection efficiency of HH514 cells is apparently in the same range as that of BJAB and DG75 cells.
As a next step HH514 cells were transfected with an EBV-based episomal vector, BC230A, which was designed for optimized gene expression and expression cloning (13) . This vector carries the episomal origin of replication, oriP, the EBNA1 gene required for episomal replication in EBV-negative cells and the regulatory elements of the immunoglobulin κ locus (14) behind an expression cassette (15) which is driven by the human cytomegalovirus immediate early promoter and enhancer. Aliquots of 10 7 cells were electroporated at room temperature with 10 µg BC230A DNA in a total volume of 300 µl RPMI1640 medium without FCS in a 0.4 cm electroporation cuvette applying 260 V and 960 µF. Transfection conditions were chosen to kill 30-50% of the cells. For cells exhibiting low transient transfection efficiencies, voltage, capacity and volume may be modified according to Baum et al. (5;  Table 1 ). After electroporation, cells were resuspended in 10 ml RPMI1640 containing 10% FCS and the cells allowed to recover overnight. The following day viable cells were counted and the cells were plated in flat bottom 96-well plates at densities of 100 and 10 cells/well in a total volume of 100 µl RPMI1640 supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin with or without PTB. In the experiment shown in Table 2 hygromycin was added at day 0 or day 6 after plating at a final concentration of 250 µg/ml. Proliferation of cells was monitored microscopically at least twice a week and the experiment finally evaluated after 4-5 weeks. In duplicate plates with 100 cells/well and PTB added proliferation occured in almost all wells and in 26 and 27 wells/plate where 10 cells/well were plated. In contrast, in none of the wells of duplicate plates with 100 and 10 cells/well, were proliferating cells detected in the absence of PTB. Addition of hygromycin on the day of plating reduced the efficiency of clonal outgrowth by a factor of at least 20-to 30-fold ( Table 2 ). The detrimental effect of adding hygromycin imediately after plating could, in part, be compensated for by addition of 5000 untransfected cells to 100 or 10 transfected HH514 cells/well. Addition of untransfected cells, however, could not support survival and proliferation of the transfected cells in the absence of PTB (Table 2) . To look for reproducibility of the selection conditions in HH514 cells several independent stable transfection assays were performed with plating of 100, 10 and 1 cell(s)/well. Hygromycin was added between days 4 and 6 after plating, depending on the microscopical evaluation of cell recovery. In 14 independent experiments the efficiency of clonal outgrowth was highly reproducible, varying between 1.7 and 10%. In two experiments the rate of transfection efficiency and clonal outgrowth was exceedingly high (21 and 37%). Extremely high transfection efficiencies have also been observed in some transient transfection experiments.
To compare the efficiency of stable transfection in HH514 cells using episomal versus non-episomal vectors two different episomal (BC230A and BC241A) and a non-episomal vector (pTG76) were included in one experiment. pTG76 is a non-episomal vector conferring hygromycin resistance from an optimized hygromycin expression cassette (16) . BC241A is identical to BC230A except that it does not contain the regulatory elements of the Igκ locus. BC241A was only slightly less effective than BC230A (2-to 3-fold), whereas pTG76 was ∼500-fold less effective than BC230A.
The EBV-negative BL cell line BL2, which is similarly sensitive to seeding at low density as HH514 cells (Fig. 1A) , has also been stably transfected following the same selection protocol using episomal as well as non-episomal vectors.
Compared with HH514 cells it is relatively easy to make stable transfectants from BJAB and DG75 cells. To see whether outgrowth of stably transfected clones of BJAB and DG75 cells was also affected by oxidative stress, stable transfection experiments similar to those described above for HH514 cells were performed with these two cell lines and BC230A and pTG76 as vectors. In contrast to HH514 cells, stable clones were obtained in nearly all experiments, including those in which PTB was omitted. For BJAB cells the efficiency of clonal outgrowth was, however, dramatically increased when PTB was included in the medium. This was particularly apparent when cells were plated at a density of 1000 or less per well in the absence of untransfected cells and hygromycin was added at the time of plating (Table 3) . Addition of untransfected cells (Table 3) rescued outgrowth of transfected cells as efficiently as a delay in addition of hygromycin (data not shown), although to a lesser extent than addition of PTB. The overall rate of outgrowth of BC230A-transfected BJAB clones was very high under optimized conditions using PTB (6-14%) and non-episomal vectors were only slightly less efficient (1.5-4%). With DG75 cells transfected clones grew out under all conditions and addition of PTB improved outgrowth only marginally. The rate of clonal outgrowth with episomal vectors varied between 2 and 8% and non-episomal vectors were ∼20-fold less efficient (data not shown). We have shown here that outgrowth of stably tansfected cell clones can be dramatically improved when antioxidants are applied during the selection procedure and when addition of the dominant selectable marker is delayed for a few days until the cells have recovered from the stress of eletroporation. This allows one to obtain transfected cell clones reproducibly and at high frequencies of cell lines that are sensitive to induction of apoptosis at low cell density and that have been virtually resistent to stable transfection up to now. Another advantage of the system is that one can be relatively sure of obtaining single cell clones and not mixtures of transfectants, provided the number of positive wells per plate is low. Using episomal vectors almost every successfully transfected cell which survives can be established as a transfected clone. Table 4 summarizes our protocol optimized for BL cells, which are exquisitely sensitive to induction of apoptosis by low cell density. Since cell density-dependent growth and sensitivity to oxidative stress are features not only of human B cells, it is likely that this protocol will turn out to be generally useful for gene transfer into many types of cells, in particular other cells of hematopoetic origin and neuronal cells (17) (18) (19) .
